Effective online directory of Australian cancer care resources (#802)

3:00 PM

Gillian Batt

Epithelial mesenchymal transition (EMT) is involved in the prostate cancer radiation resistance  (#803)

3:00 PM

Lei Chang

Docetaxel blood management: analytical validation of a rapid automated immunoassay (#804)

3:00 PM

Patrick I Cook

The consumer role in innovation in cancer treatment and care (#805)

3:00 PM

Kathy Smith

‘Knowledge is power’: coping with the risk and uncertainty of familial breast cancer (#806)

3:00 PM

Louise E Heiniger

Surveillance of stage III colon cancer in South West Sydney (#807)

3:00 PM

Florian Honeyball

The development of an internationally-valid cancer-specific multi-attribute utility instrument (MAUI) from the EORTC core health-related quality of life (HRQOL) questionnaire, QLQ-C30 (#808)

3:00 PM

Madeleine T King

Correlation of grade & hormone-receptor status with stage in node-positive, non-metastatic breast cancer (#809)

3:00 PM

Stephanie Lim

Development of a survivorship project – ‘positive change for life’ (#811)

3:00 PM

Helen Mclauchlan

Engaging youth in reducing the burden of liver cancer in culturally and linguistically diverse (CALD) communities (#812)

3:00 PM

Mamta Porwal

Differential effectiveness of family and friends in the promotion of healthy lifestyle behaviours among adolescents (#813)

3:00 PM

Ivanka Prichard

Radioembolization with yttrium-90 microspheres is associated with a significantly improved survival compared to conservative therapy after treatment of hepatic tumors: A large single center experience of 537 patients (#814)

3:00 PM

Akshat Saxena

Incidence of acute phase reactions (APRs) in patients with advanced cancer or multiple myeloma (MM) And bone metastases/lesions following treatment with denosumab or zoledronic acid (ZA) (#815)

3:00 PM

Nina Singh RN

After treatment: profile and predictors of long-term morbidity in breast cancer survivors (#816)

3:00 PM

Yuan Tian